AxiLona EL-100 Microarray Analyzer
Multiplex Nucleic Acid Detection
Key Facts
About Axbio
Axbio is a privately-held biotechnology company pioneering a foundational Bio-CMOS platform that merges semiconductor manufacturing with biology to create next-generation tools for sequencing and multiplex molecular diagnostics. Its core technology centers on a proprietary, high-density nanopore sequencing chip and an electrochemical microarray detection system, aimed at delivering ultra-high throughput and low-cost instruments and consumables. With a seasoned leadership team from Silicon Valley and strong backing from global venture capital, the company is advancing its first commercial product, the AxiLona EL-100 microarray analyzer, through regulatory approval in China while developing its flagship AxiLona AXP-100 nanopore sequencer. Axbio operates at the intersection of multiple high-growth markets, including genomics, precision diagnostics, and synthetic biology.
View full company profile